AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

RecruitingNAAges 18 Years - 110 YearsFemaleJohns Hopkins Bloomberg School of Public Health
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to understand PrEP user choices, preferences and implementation impact of the roll-out of long-acting injectable PrEP alongside oral PrEP among women in Blantyre, Malawi.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: The population for this research includes women aged 18 years or older at risk of HIV who initiated injectable or oral PrEP at one of the 20 Blantyre sites supported through PathToScale. PathToScale supports various types of facilities including public health clinics, drop-in centers for prioritized populations (DICs), and private hospitals/clinics. Those eligible for sampling are as follows: * Adult women โ‰ฅ18 years; and * Initiated PrEP (injectable or oral) at the implementing facilities and lost to follow up within prior 2 years prior to sampling; and * Lost-to-follow-up (missed their PrEP visit by โ‰ฅ3 months and for whom outcomes are unknown); and * Has a registered phone number for contact Those eligible for tracing are as follows: * Women sampled per eligibility criteria above; and * Women who have indicated permission for in-person follow-up Health Care Providers, Implementing Partners, Ministry of Health (MOH) Stakeholers * providers and implementing partners from PathtoScale, and Ministry of Health stakeholders will be consented to participate in in-depth-interviews Exclusion Criteria: Those excluded from sampling or tracing include: * Women who have an EMR record of a documented case of discontinuation of PrEP in consultation with a provider; or * Women who are known to have died; or * Women who have EMR documented transfers out of PathToScale supported facilities; or * Women refusing follow-up via phone on their ScanForm; or * Women refusing follow-up in person (during phone tracing); or * Women who do not speak Chichewa or English; or * Men (excluded from client interviews only)
๐Ÿ’Š

What it tests

  • Tracing Strategy
๐Ÿ“

Where

1 site
Johns Hopkins Research Project Malawi
Blantyre, Malawi
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy